Extracorporeal strategies for the removal of middle molecules.

Extracorporeal strategies for the removal of middle molecules.

Item
http://www.wikidata.org/entity/Q36427410
Sodium potassium adenosine triphosphatase (Na/K-ATPase) as a therapeutic target for uremic cardiomyopathy.The role of fibroblast growth factor 23 and Klotho in uremic cardiomyopathy.Uremic cardiomyopathy: an underdiagnosed disease.The impact of arteriovenous fistulae on the myocardium: the impact of creation and ligation in the transplant era.Uraemia: an unrecognized driver of central neurohumoral dysfunction in chronic kidney disease?Uremic cardiac hypertrophy is reversed by rapamycin but not by lowering of blood pressure.Design and methods of the REMOVAL-HD study: a tRial Evaluating Mid cut-Off Value membrane clearance of Albumin and Light chains in HaemoDialysis patients.Effect of plasma sodium concentration on blood pressure regulators during hemodialysis: a randomized crossover study
P2860

Extracorporeal strategies for the removal of middle molecules.

Item
http://www.wikidata.org/entity/Q36427410
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Extracorporeal strategies for the removal of middle molecules.
@ast
Extracorporeal strategies for the removal of middle molecules.
@en
type
label
Extracorporeal strategies for the removal of middle molecules.
@ast
Extracorporeal strategies for the removal of middle molecules.
@en
prefLabel
Extracorporeal strategies for the removal of middle molecules.
@ast
Extracorporeal strategies for the removal of middle molecules.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P356
P1433
P1476
Extracorporeal strategies for the removal of middle molecules.
@en
P2093
P2860
P304
P31
P356
10.1111/J.1525-139X.2006.00135.X
P433
P478
P577
P698